Obagi Medical Products, commonly referred to as Obagi, is a leading name in the skincare industry, headquartered in the United States. Founded in 1988, the company has established itself as a pioneer in developing innovative skincare solutions, particularly in the realm of prescription-strength products. Obagi's primary focus areas include anti-ageing, skin health, and pigmentation correction, catering to both professional and consumer markets. With a commitment to scientific research and dermatological expertise, Obagi offers a range of unique products, including the renowned Obagi Nu-Derm System, which is designed to transform skin at the cellular level. The brand's dedication to quality and efficacy has earned it a strong market position, making it a trusted choice among skincare professionals and consumers alike. Notable achievements include numerous awards for product innovation and a loyal customer base that spans across major operational regions worldwide.
How does Obagi's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Obagi's score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Obagi, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. As a merged entity under Obagi Cosmeceuticals LLC, it inherits climate commitments and initiatives from its parent company, Waldencast plc. However, there are no documented reduction targets or significant climate pledges reported at this time. The absence of emissions data suggests that Obagi may still be in the process of establishing its own climate strategy or reporting framework. As part of the broader industry context, companies are increasingly focusing on sustainability and carbon reduction, often aligning with frameworks such as the Science Based Targets initiative (SBTi) to set ambitious climate goals. While specific emissions figures are not available, Obagi's commitment to sustainability will likely evolve as it integrates more comprehensive climate strategies in line with industry standards.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Obagi has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.